Chemoinformaics analysis of 7-Hydroxy-3-(4-hydroxybenzylidene)chroman-4-one
Molecular Weight | 268.268 | nRot | 1 |
Heavy Atom Molecular Weight | 256.172 | nRig | 19 |
Exact Molecular Weight | 268.074 | nRing | 3 |
Solubility: LogS | -3.394 | nHRing | 1 |
Solubility: LogP | 2.549 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 2 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 32 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 2 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
No. of Oxygen atom | 4 | No. of Arom Bond | 12 |
nHA | 4 | APOL | 37.9295 |
nHD | 2 | BPOL | 14.6425 |
QED | 0.78 |
Synth | 2.31 |
Natural Product Likeliness | 0.681 |
NR-PPAR-gamma | 0.012 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.012 |
Pgp-sub | 0.001 |
HIA | 0.005 |
CACO-2 | -4.786 |
MDCK | 0.0000143 |
BBB | 0.081 |
PPB | 0.981549 |
VDSS | 0.629 |
FU | 0.018347 |
CYP1A2-inh | 0.972 |
CYP1A2-sub | 0.109 |
CYP2c19-inh | 0.778 |
CYP2c19-sub | 0.058 |
CYP2c9-inh | 0.697 |
CYP2c9-sub | 0.89 |
CYP2d6-inh | 0.539 |
CYP2d6-sub | 0.869 |
CYP3a4-inh | 0.881 |
CYP3a4-sub | 0.258 |
CL | 14.859 |
T12 | 0.85 |
hERG | 0.036 |
Ames | 0.939 |
ROA | 0.613 |
SkinSen | 0.922 |
Carcinogencity | 0.839 |
EI | 0.814 |
Respiratory | 0.484 |
NR-Aromatase | 0.828 |
Antiviral | No |
Prediction | 0.604148 |